We believe that not only scientific research and innovation, but the source of vitality builds the foundation for Hzymes sustainable development. With 20 years of experience in technical accumulation, Hzymes Biotechnology Co., Ltd. (Hzymes-prk) has become the primary manufacture of raw materials in the IVD industry and developed win-win cooperation with various institutions.
We are committed to the mission that “technological innovation drives the progress of bio-industry and continues to create values for customers.” Today, Hzymes creates five innovative enzyme creation technology platforms to provide the consistent large-scale output of the highest-quality enzymes for customers worldwide. We take global raw materials supply safety as a responsibility and dedicate to improving human lives and health.
Why People Trust Us
Hzymes Biotech has established R&D and production bases in Wuhan, Shanghai, Suzhou, and Qingdao. The company is going forward by virtue of multiple technology platforms and multiple products.
Nearly 20 years of technology accumulation, Hzymes Biotech has become the only company in China that has 5 major IVD raw material enzyme creation technology platforms at the same time.
As one of the most important innovations in Hzymes Biotech, the stability of fructose-based peptide oxidase (FPOX) was improved by multiple molecular evolutions, and the half-life of the optimal mutant was increased by nearly 1000 times, reaching the international advanced level..
Hzymes Biotech attaches great importance to the construction of a talented team. It has a team of professional management talents with working experience in multinational companies and listed companies, and more than 50% of its technical staff hold Masters or Doctoral degrees.
With Latest Research & Technology
- Production and sales of core raw materials such as enzymes / coenzymes / enzyme substrates / antigens / antibodies )
- OEM reagent/solution provision, production foundry for holder system
- IVD Reagent Technical Services.
- Strategic development technology holdings for specialty products (molecular diagnostic all-in-one machine, bilirubin biosensor, enzymatic glycated hemoglobin biosensor, etc.)